§ 212.110. How must I maintain records of my production of PET drugs?
106 words·~1 min read·
/us/cfr/t21/s§ 212.110·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Record availability. Records must be maintained at the PET drug production facility or another location that is reasonably accessible to responsible officials of the production facility and to employees of FDA designated to perform inspections.
(b)Record quality. All records, including those not stored at the inspected establishment, must be legible, stored to prevent deterioration or loss, and readily available for review and copying by FDA employees.
(c)Record retention period. You must maintain all records and documentation referenced in this part for a period of at least 1 year from the date of final release, including conditional final release, of a PET drug product.